Could Investing in Vaxart Make You a Millionaire?
Thanks to its innovative vaccine technology platform and recently fast-tracked COVID-19 vaccine candidate, Vaxart is likely a millionaire-maker stock.
Better Buy: Eli Lilly vs. Johnson & Johnson
These two healthcare behemoths have something to offer most investors.
Forget Vertex, Biogen Is a Better Value Stock
Biogen is more profitable, more innovative, and its stock may be undervalued to boot.
Everything You Need To Know About Zocdoc
Helping doctors and patients find each other is an essential role in the U.S. healthcare system.
What Will the World for Nonprofits Look Like After COVID-19?
Sadly, many charities won’t make it out of the pandemic, but it's easy to predict which ones will.
Better Coronavirus Stock: VBI Vaccines or Vaxart?
A company's vaccine manufacturing capabilities can make a world of difference.
Smart Investors Might Consider Buying This Coronavirus Stock That Just Popped 96%
Vaxart’s aggressive moves to scale up its vaccine-manufacturing capabilities bode well for the company’s future.
Could Edwards Lifesciences Be a Millionaire-Maker Stock?
Strong revenue growth and low debt make this stock a winner.
Everything You Need to Know About GoodRx
Could this drug couponing start-up be headed for IPO or is it a takeover target? Either way, it's helping consumers save billions at the pharmacy.
Better Buy: Invitae vs. Illumina
Illumina is practically an institution in the biotech sector, but can it outgrow an aggressive competitor?
Is Sage Therapeutics a Buy?
With its recent clinical trial stumble and falling revenues for its only approved drug on the market, Sage may be in trouble.
Everything You Need To Know About Teladoc
Based on its recent explosion of growth, Teladoc is making waves in telemedicine.
Got $1,000? Here Are 3 Nonprofits Deserving of Your Money
Healthcare nonprofits are a great option for a charitable donation, and these three organizations are among the best.
Everything You Need to Know About At-Home Testing Start-Ups 23andMe, Ancestry, and Everlywell
The direct-to-consumer health testing market is still nascent, but these companies are leading the way.
3 Top Animal-Health Companies to Buy in June
With these three animal-health stocks, your portfolio will be stronger than ever.
Better Coronavirus Stock: Grifols or Novartis?
Each company has a triad of COVID-19 projects, but they aren't in direct competition.
Better Buy: Pfizer vs. Merck
Only one of these two pharma titans has a history of growth.
Better Coronavirus Stock: Thermo Fisher Scientific or Roche?
Both companies have moved aggressively to produce diagnostic tests for COVID-19, and both are positioned for growth.
Here’s How The COVID-19 Pandemic Has Affected Healthcare Professionals
The coronavirus crisis thrusts medical workers into the global spotlight, but many of their new struggles remain invisible.
So You Want To Be A Doctor? Take These 3 Steps First
Getting into medical school has never been more competitive, so it pays to do some preliminary research before setting your sights on a career as a doctor.